Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Identify whether a Backdoor Roth is right for you, focusing on income, taxes, and long-term retirement goals.
23,905 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
This week brought a notable pullback in AI hardware names, including CoreWeave. Read a clear, practical look at what ...
A Detroit autoworker’s dream of winning margins meets a global market that’s increasingly dependent on China. This ar...
Itron stock is making big moves this week, with investors buzzing about quarterly results and smart-city demand. This...
Alphabet surged more than 70% over the past year, but the question remains: is it too late to buy? This guide looks a...
A dramatic intraday rise in The Trade Desk shares grabbed headlines. This article breaks down the catalysts, what the...
When a top executive makes bold moves with his own money, it’s hard not to notice. This article dives into what berks...
A street-side incident involving a public figure can ripple into everyday finances. This guide breaks down the money ...
A renewable-powered data-center company, Iren, surged after unveiling a multi-year Nvidia partnership and ambitious A...
In a market where dividends among healthcare firms can be elusive, two names stand out for investors seeking income n...
As 2026 unfolds, two very different paths compete for investor attention: robinhood markets interactive brokers. This...
Curious about how to participate in a SpaceX IPO? This guide breaks down practical steps, risk factors, and smart all...